In myeloproliferative diseases, JAK and STAT protein mutations have been comprehensively characterized and have been linked to hyperactivity of the JAK/STAT pathway which eventually leads to unrestricted cell proliferation (Vainchenker et al., 2018; Baldini et al., 2021). The gene discussed is SOAT1; the disease is myeloproliferative disorder.